Social Sustainability


The human capital of AM Instruments is made up of more than 100 people.

AM Instruments prioritizes their personal and professional growth, their health and their safety. Against all types of discrimination and always in defense of equal opportunities, the company invests on human capital as a priority.


AM has always been committed to facilitating the inclusion of people with disabilities in the way of work. We comply with the provisions of the law without resorting to exemptions that allow us to comply with the terms of the law against the payment of monetary sums.

Staff growth rate

  • 2016: +32%
  • 2017: +9%
  • 2018: +5%
  • 2019: +19%

Composition of personnel



Composition of management



The insertion in the social fabric is witnessed by the activities that AM Instruments has always carried on by supporting associations and no-profit organizations that defend the health and well-being of the less fortunate.

Founded in 1993 on the initiative of some parents of sick children and oncology doctors at the “G.Gaslini” Institute in Genoa, it aims to give hope to the children affected by this cancer of the pediatric age and provide support to scientific research.

Dynamo Camp is a Recreational Therapy camp, the first in Italy, specifically designed to host children and young people who are sick, in therapy or in the post-hospitalization period, free of charge for holidays and recreation.

This Italian association, officially recognized in Zambia as an international non-governmental organization, has carried out intense development cooperation activities since 2003, with projects in the field of basic assistance, education, health and work.

The Italian association Vivi Down Onlus was founded in 1988 to provide people with Down syndrome and their families with all possibile support and assistance needed to sustain the difficulties that this disability involves.

The association is a non-profit organization that provides assistance to patients affected by DiGeorge syndrome, to their families, to the scientific community and to the public in order to inform, support clinical research, promote the social inclusion of people affected by this rare genetic syndrome.